Stephen K. Youngster

2.1k citations

28 papers · 1.7k indexed · h-index 22

Molecular Biology
Neurology top 2%
Cellular and Molecular Neuroscience top 5%
Radiology, Nuclear Medicine and Imaging top 10%
Oncology

Co-authors: Richard E. Heikkila James Bausch William J. Nicklas M. Victoria Kindt Daniel F. Wyss Michael J. Grace Ronald Bordens Thomas P. Singer
Topics: Parkinson's Disease Mechanisms and Treatments (14 papers)Neuroscience and Neuropharmacology Research (7 papers)Neurotransmitter Receptor Influence on Behavior (5 papers)
Cited by: Neurology Cellular and Molecular Neuroscience Hepatology
Journals: Proceedings of the National Academy of Sciences Biochemistry Advanced Drug Delivery Reviews
Partner nations: United States Netherlands Canada

In The Last Decade

Stephen K. Youngster

28 papers receiving 1.6k citations

Peers

Countries citing papers authored by Stephen K. Youngster

Since Specialization

Citations

This map shows the geographic impact of Stephen K. Youngster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen K. Youngster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen K. Youngster more than expected).

Fields of papers citing papers by Stephen K. Youngster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen K. Youngster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen K. Youngster. The network helps show where Stephen K. Youngster may publish in the future.

Co-authorship network of co-authors of Stephen K. Youngster

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen K. Youngster. A scholar is included among the top collaborators of Stephen K. Youngster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen K. Youngster. Stephen K. Youngster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Downregulation of HER3 by a Novel Antisense Oligonucleotide, EZN-3920, Improves the Antitumor Activity of EGFR and HER2 Tyrosine Kinase Inhibitors in Animal Models 2013 ·Molecular Cancer Therapeutics ·Yaming Wu,Yixian Zhang,Maoliang Wang,Qi Li,Zhengxing Qu,(unknown),Patricia Kraft,Steve Kim,Ying Gao,(unknown),Stephen K. Youngster,Ivan D. Horak,Lee M. Greenberger	36
2	Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications 2002 ·Advanced Drug Delivery Reviews ·(unknown),Stephen K. Youngster,Michael J. Grace,James Bausch,Ronald Bordens,Daniel F. Wyss	313
3	Structure, Biology, and Therapeutic Implications of Pegylated Interferon Alpha-2b 2002 ·Current Pharmaceutical Design ·Stephen K. Youngster,(unknown),Michael J. Grace,James Bausch,Ronald Bordens,Daniel F. Wyss	67
4	Identification of polyamides that enhance adenovirus-mediated gene expression in the urothelium 2001 ·Gene Therapy ·(unknown),H Engler,Todd Machemer,(unknown),(unknown),Suganto Sutjipto,(unknown),Stephen K. Youngster,Tak Mao Chan,James Bausch,(unknown),Ole Hindsgaul,T. L. NAGABHUSHAN	39
5	Structural and Biologic Characterization of Pegylated Recombinant IFN- α 2b 2001 ·Journal of Interferon & Cytokine Research ·Michael J. Grace,Stephen K. Youngster,Gerry Gitlin,(unknown),(unknown),(unknown),Sheila Jacobs,Diana Brassard,James Bausch,Ronald Bordens	137
6	Studies on the Characterization of the Inhibitory Mechanism of 4′‐Alkylated 1‐Methyl‐4‐Phenylpyridinium and Phenylpyridine Analogues in Mitochondria and Electron Transport Particles 1994 ·Journal of Neurochemistry ·Martin R. Gluck,Stephen K. Youngster,Rona R. Ramsay,Thomas P. Singer,William J. Nicklas	28
7	Interaction of 1‐Methyl‐4‐Phenylpyridinium Ion (MPP⁺) and Its Analogs with the Rotenone/Piericidin Binding Site of NADH Dehydrogenase 1991 ·Journal of Neurochemistry ·Rona R. Ramsay,M. Krueger,Stephen K. Youngster,Martin R. Gluck,John E. Casida,Thomas P. Singer	171
8	A new class of powerful inhibitors of monoamine oxidase A 1990 ·Biochemical and Biophysical Research Communications ·(unknown),Rona R. Ramsay,Stephen K. Youngster,(unknown)	3
9	4′-Alkylated analogs of 1-methyl-4-phenylpyridinium ion are potent inhibitors of mitochondrial respiration 1990 ·Biochemical and Biophysical Research Communications ·Stephen K. Youngster,Martin R. Gluck,Richard E. Heikkila,William J. Nicklas	16
10	In vivo intracerebral microdialysis studies in rats of MPP+ (1-methyl-4-phenylpyridinium) analogs and related charged species 1990 ·Journal of Medicinal Chemistry ·Hans Rollema,(unknown),Raymond G. Booth,Patricia Caldera,Peter Lampen,Stephen K. Youngster,Anthony J. Trevor,Noreen Naiman,Neal Castagnoli	27
11	Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. II. Evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase-catalyzed oxidation of MPTP analogs. 1989 ·Journal of Pharmacology and Experimental Therapeutics ·Stephen K. Youngster,William J. Nicklas,Richard E. Heikkila	31
12	Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs. 1989 ·Journal of Pharmacology and Experimental Therapeutics ·Stephen K. Youngster,Patricia K. Sonsalla,Beth‐Anne Sieber,Richard E. Heikkila	37
13	Oxidation of Analogs of l‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine by Monoamine Oxidases A and B and the Inhibition of Monoamine Oxidases by the Oxidation Products 1989 ·Journal of Neurochemistry ·Stephen K. Youngster,Kathleen A. McKeown,(unknown),Rona R. Ramsay,Richard E. Heikkila,Thomas P. Singer	49
14	Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2′Me-MPTP 1988 ·European Journal of Pharmacology ·M. Victoria Kindt,Stephen K. Youngster,Patricia K. Sonsalla,Roger C. Duvoisin,Richard E. Heikkila	28
15	Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. 1988 ·Proceedings of the National Academy of Sciences ·Richard E. Heikkila,M. Victoria Kindt,Patricia K. Sonsalla,Andrew Giovanni,Stephen K. Youngster,Kathleen A. McKeown,Thomas P. Singer	46
16	Studies with the neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogs 1988 ·Toxicology ·Richard E. Heikkila,Stephen K. Youngster,(unknown),Andrew Giovanni,Patricia K. Sonsalla	5
17	1-Methyl-4-cyclohexyl-1,2,3,6-tetrahydropyridine (MCTP): an alicyclic MPTP-like neurotoxin 1987 ·Neuroscience Letters ·Stephen K. Youngster,Walfred S. Saari,Richard E. Heikkila	11
18	Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse. 1987 ·Journal of Pharmacology and Experimental Therapeutics ·Patricia K. Sonsalla,Stephen K. Youngster,M. Victoria Kindt,Richard E. Heikkila	52
19	IV. MPTP, MPP+ and mitochondrial function 1987 ·Life Sciences ·William J. Nicklas,Stephen K. Youngster,M. Victoria Kindt,Richard E. Heikkila	204
20	1-Methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine (2′-CH3-MPTP) is a more potent dopaminergic neurotoxin than MPTP in mice 1986 ·European Journal of Pharmacology ·Stephen K. Youngster,Roger C. Duvoisin,Arthur Hess,Patricia K. Sonsalla,M. Victoria Kindt,Richard E. Heikkila	44

About Stephen K. Youngster

Stephen K. Youngster is a scholar working on Neurology, Cellular and Molecular Neuroscience and Oncology, having authored 28 papers that have together received 1.7k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (14 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). The work is most often cited by research in Neurology (626 citations), Cellular and Molecular Neuroscience (585 citations) and Hepatology (139 citations). Stephen K. Youngster has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Richard E. Heikkila, James Bausch, William J. Nicklas, M. Victoria Kindt, Daniel F. Wyss, Michael J. Grace, Ronald Bordens, Thomas P. Singer, Rona R. Ramsay and Patricia K. Sonsalla. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biochemistry and Advanced Drug Delivery Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact